What happens when you take naproxen with fish oil?
Naproxen is a long-acting NSAID that blocks COX-1 and COX-2. COX-1 inhibition reduces platelet thromboxane A2 production, which impairs platelet aggregation and slightly prolongs bleeding time. Compared with low-dose aspirin, naproxen's antiplatelet effect is reversible and shorter-lived, but it is still measurable at therapeutic doses.
Fish oil supplies the long-chain omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). These fatty acids are incorporated into platelet membranes and shift eicosanoid production toward less aggregatory prostaglandins (PGI3) and thromboxanes (TXA3). At high doses they also reduce thrombin generation, lower fibrinogen, and modestly inhibit factor V and factor VII activity, all of which add up to mild antiplatelet and antithrombotic effects.
When the two are combined, the effects on platelet function stack on top of each other. The interaction is generally mild but becomes clinically meaningful at higher doses or in patients already at elevated bleeding risk.
Why is this important?
For a healthy adult taking a standard 1-2 g daily fish oil supplement and occasional naproxen for a headache or sore back, the additional bleeding risk is small. The picture changes when:
- Naproxen is used chronically for arthritis or other persistent pain
- Fish oil is taken at cardioprotective doses (3-4 g/day or more) as found in prescription products like Lovaza or Vascepa
- The person is also on aspirin, warfarin, a direct oral anticoagulant, clopidogrel, or another antiplatelet
- There is a history of GI ulcer, intracranial bleed, or a bleeding disorder
- The person is over 65, on corticosteroids, drinks alcohol heavily, or has uncontrolled hypertension
- Surgery, dental work, or an invasive procedure is upcoming
Even in low-risk people, naproxen alone is associated with GI bleeding, and clinical interaction databases such as Drugs.com's professional monograph note that fish oil may potentiate this effect. Large meta-analyses have not shown a strong increase in major bleeds at typical supplement doses, but the conservative position is to assume mild additive risk.
What should you do?
If you take fish oil at standard dietary doses (around 1-2 g/day of combined EPA+DHA) and use naproxen only occasionally, you generally do not need to change anything. Take naproxen with food to reduce GI irritation, use the lowest effective dose, and limit duration to a few days at a time.
If you take prescription-strength omega-3 (3-4 g/day or more) or a high-dose supplement, talk to your clinician before starting chronic naproxen, and prefer acetaminophen for mild pain when possible. Watch for warning signs of bleeding: unusual bruising, prolonged bleeding from cuts, black tarry stools, blood in urine, nosebleeds, or new severe headache.
Most surgical centers recommend stopping high-dose fish oil one to two weeks before elective surgery, although routine doses may be safer than once thought. Follow your surgeon's specific instructions.
Which specific products are affected?
The interaction applies to all naproxen products - Aleve (over-the-counter), Naprosyn (prescription), and Anaprox - and to all marine omega-3 sources, including standard fish oil, krill oil, cod liver oil, algae-derived DHA/EPA, and prescription omega-3 products (Lovaza, Omtryg, Vascepa/icosapent ethyl).
Other NSAIDs interact in the same way through the same COX-1 mechanism. These include ibuprofen (Advil, Motrin), diclofenac, meloxicam, indomethacin, ketorolac, and aspirin. The selective COX-2 inhibitor celecoxib has less effect on platelets but still carries some bleeding risk in combination.
The bottom line
At typical doses, naproxen plus fish oil is a low-to-moderate bleeding risk, but the risk rises with higher doses, longer use, age, and other blood thinners. Use the lowest effective NSAID dose, watch for bleeding signs, and check with your clinician before combining high-dose fish oil with chronic NSAID therapy.